Systemic therapy options following first-line chemoimmunotherapy in small-cell lung cancer

Nearly all patients with extensive-stage small-cell lung cancer (ES-SCLC) relapse following first-line etoposide plus platinum (EP) with or without immune checkpoint inhibition. Topotecan and amrubicin are chemotherapies approved for these patients. The toxicities of these chemotherapies are signifi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Thorac Dis
Hlavní autor: Pacheco, Jose M.
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2020
Témata:
Review Article on Small Cell Lung Cancer
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7656348/
https://ncbi.nlm.nih.gov/pubmed/33209465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2020.03.67
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky